These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 6929006)

  • 21. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland.
    Snedeker SM; Diaugustine RP
    Prog Clin Biol Res; 1996; 394():211-53. PubMed ID: 8778798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impacts of chemicals on liver cancer risk.
    Wogan GN
    Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of environmental and occupational cancer.
    Boffetta P
    Oncogene; 2004 Aug; 23(38):6392-403. PubMed ID: 15322513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
    Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
    Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radon-progeny exposure and lung cancer risk in a cohort of Newfoundland fluorspar miners.
    Morrison HI; Villeneuve PJ; Lubin JH; Schaubel DE
    Radiat Res; 1998 Jul; 150(1):58-65. PubMed ID: 9650603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-examination of the ED01 study--risk assessment using time.
    Fundam Appl Toxicol; 1981; 1(1):88-123. PubMed ID: 7184778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tumor and work: 20 years after "The causes of cancer" by Doll and Peto].
    Cocco P
    Med Lav; 2000; 91(1):14-23. PubMed ID: 10822945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The assessment of low-dose carcinogenicity.
    Armitage P
    Biometrics; 1982 Mar; 38 Suppl():119-39. PubMed ID: 7046818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bladder cancer epidemiology and pathogenesis.
    Ross RK; Jones PA; Yu MC
    Semin Oncol; 1996 Oct; 23(5):536-45. PubMed ID: 8893866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces.
    Ugnat AM; Luo W; Semenciw R; Mao Y;
    Chronic Dis Can; 2004; 25(2):7-15. PubMed ID: 15554606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
    Bogen KT; Gold LS
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cancer and prevention].
    Dreyer L; Winther JF
    Ugeskr Laeger; 2001 Jan; 163(4):430-8. PubMed ID: 11218778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
    Shields PG
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of occupational carcinogens: perspectives opened by the evaluation of risks and preventive actions].
    Le Gales C; Oudiz A
    Rev Epidemiol Sante Publique; 1986; 34(6):387-99. PubMed ID: 3550964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinogen exposure and epigenetic silencing in bladder cancer.
    Marsit CJ; Karagas MR; Schned A; Kelsey KT
    Ann N Y Acad Sci; 2006 Sep; 1076():810-21. PubMed ID: 17119258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Asbestos-related carcinogenic risk].
    Marek K
    Med Pr; 2002; 53(6):447-9. PubMed ID: 12701533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.